Basics of diagnosis and treatment of venous thromboembolism
Journal of Thrombosis and Haemostasis · 2025
DOI: 10.1016/j.jtha.2025.01.009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Catrin Cox und 1 weiteren Autor:innen. Beteiligte Einrichtung: Thrombosis and Haemophilia Centre, Guy's & St Thomas' NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Venous Thromboembolism, Anticoagulants, Pulmonary Embolism, Venous Thrombosis. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Venous thromboembolism (VTE), comprising deep vein thrombosis and pulmonary embolism (PE), is common and associated with significant morbidity and mortality. The symptoms and signs of VTE are nonspecific. Well-established integrated diagnostic strategies combining clinical probability scores and D-dimer are used to identify patients with a low probability of VTE, where the diagnosis can be safely excluded without imaging. In patients with confirmed VTE, anticoagulation is the mainstay of treatment. However, patients with high-risk features at presentation may benefit from advanced reperfusion therapies such as thrombolysis and/or interventional approaches to reduce early mortality and/or long-term morbidity. The advent of direct oral anticoagulants has greatly simplified the treatment of VTE for most patients, with a persisting role for low molecular weight heparin and vitamin K antagonists in select patient groups. Following an initial 3 to 6 months of anticoagulation, those with major transient provoking factors can safely discontinue anticoagulation. Balancing the risk of recurrent VTE and bleeding risk is central to decisions regarding long-term anticoagulation, and patients should be included in shared decision-making. Assessment and recognition of common long-term complications such as postthrombotic syndrome and post-PE syndrome are also essential, given they are associated with significant adverse impact on long-term quality of life, with a significant risk of mortality associated with the less frequent complication of chronic thromboembolic pulmonary hypertension. This review provides a basic overview and framework for the diagnostic approach to deep vein thrombosis and PE, risk stratification of confirmed diagnoses, and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thrombosis and Haemophilia Centre, Guy's & St Thomas' NHS Foundation Trust, London, UK.
- King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK; Institute of Pharmaceutical Sciences, King's College London, London, UK. Electronic address: lar…
Zitieren
APA
Cox, C., & Roberts, L. N. (2025). Basics of diagnosis and treatment of venous thromboembolism. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.01.009
Vancouver
Cox C, Roberts LN. Basics of diagnosis and treatment of venous thromboembolism. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.01.009
BibTeX
@article{Cox2025,
author = {Cox, Catrin and Roberts, Lara N},
title = {Basics of diagnosis and treatment of venous thromboembolism},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
doi = {10.1016/j.jtha.2025.01.009}
}
EUVIMED